Insider trading · Q3 2026 · CIK 1388320

Actinium Pharmaceuticals, Inc. (ATNM) insider trading.

In Q3 2026, insiders at Actinium Pharmaceuticals, Inc. reported 7 non-derivative transactions on 8 Forms 3, 4 and 5: 0 open-market purchases and 0 sales.

Transactions
7
Purchases (P)
0
Sales (S)
0
Net shares, P minus S
0
Insiders
6
Last filed
2026-09-04

Insiders

InsiderRelationshipTransactionsBuysSales
Seth SandeshDirector, Officer · Chief Executive Officer200
Chell Jeffrey W.Director100
Steinhart Richard IDirector100
Almenoff June SherieDirector100
Shetty AjitDirector100
Nicholson, C. DavidDirector100

Transactions

7 non-derivative rows, newest transaction first. Shares and prices as filed.
DateInsiderCodeSharesPriceOwned afterFiling
2026-09-02Chell Jeffrey W.A (A)61,600$061,600Form 4
2026-09-02Steinhart Richard IA (A)62,800$063,116Form 4
2026-09-02Seth SandeshA (A)1,027,274$01,965,355Form 4
2026-09-02Seth SandeshA (A)753,600$0938,081Form 4
2026-09-02Almenoff June SherieA (A)18,000$018,000Form 4
2026-09-02Shetty AjitA (A)61,600$062,357Form 4
2026-09-02Nicholson, C. DavidA (A)62,800$063,300Form 4

Transaction codes in this quarter

Get ATNM insider transactions through the API

Request with your API key
curl "https://sec-api.dev/api/v1/insider-transactions?period=2026q3&cik=1388320&limit=100" \
  -H "Authorization: Bearer $SEC_API_KEY"

Insider trading API guide · ATNM company page · Actinium Pharmaceuticals, Inc. on SEC.gov

Questions

Are insiders buying or selling Actinium Pharmaceuticals, Inc. (ATNM)?

In Q3 2026, insiders at Actinium Pharmaceuticals, Inc. reported 7 non-derivative transactions on 8 Forms 3, 4 and 5: 0 open-market purchases and 0 sales. Grants, tax withholding and option exercises are counted as transactions but are not purchases or sales.

Where do these Actinium Pharmaceuticals, Inc. insider trades come from?

From the SEC Insider Transactions Data Sets for Q3 2026, which republish the Forms 3, 4 and 5 filed on EDGAR. Each row links to its filing on SEC.gov.

Source: SEC Insider Transactions Data Sets, Q3 2026, retrieved 2026-10-27. Footnotes, derivative holdings and amendments are in the linked filings. Not investment advice.

Plain-text version for agents and LLMs: /insider-trading/atnm.md

Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.